Literature DB >> 767080

Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.

M M Singh.   

Abstract

Data on the subjective responses to neuroleptic treatment and their prognostic implications are reported from a multidimensional double-blind study of the pharmacotherapeutic process in schizophrenia. From these data it seems that the occurrence of a dysphoric response in the course of neuroleptic treatment is associated with a less favorable therapeutic response and long-term prognosis. It is suggested that the dysphoric responders, many of whom belong to the category of nuclear or poor prognosis schizophrenia, may be fundamentally different from the others.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 767080

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN: 0012-3714


  11 in total

Review 1.  Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.

Authors:  A George Awad
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

2.  [The initial dysphoric reaction (IDR) to the first dose of neuroleptics].

Authors:  B Graf Schimmelmann; M Schacht; C Perro; M Lambert
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

3.  Specificity of the Relationships Between Dysphoria and Related Constructs in an Outpatient Sample.

Authors:  Vladan Starcevic; David Berle; Kirupamani Viswasam; Anthony Hannan; Denise Milicevic; Vlasios Brakoulias; Erin Dale
Journal:  Psychiatr Q       Date:  2015-12

4.  The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment.

Authors:  Michael E Ballard; Ana M Basso; Kelly B Gallagher; Kaitlin E Browman; Gerard B Fox; Karla U Drescher; Gerhard Gross; Michael W Decker; Lynne E Rueter; Min Zhang
Journal:  Psychopharmacology (Berl)       Date:  2006-11-09       Impact factor: 4.530

5.  The Fluoxetine and Suicide Controversy : A Review of the Evidence.

Authors:  D Healy
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

6.  Prediction of outcome in schizophrenia using the subjective response to a test dose of a neuroleptic.

Authors:  M Borde; E J Davis; L N Sharma
Journal:  Indian J Psychiatry       Date:  1991-01       Impact factor: 1.759

Review 7.  Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

Authors:  Martin Lambert; Dieter Naber
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics.

Authors:  John G Csernansky; Emily K Schuchart
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 9.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

Review 10.  The impact of subjective well-being under neuroleptic treatment on compliance and remission.

Authors:  Walter de Millas; Martin Lambert; Dieter Naber
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.